Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2012
07/18/2012CN101296914B Derivative having PPAR agonistic activity
07/18/2012CN101279965B New compounds separated from rouge vegetal, preparation, medicinal composition and use thereof
07/18/2012CN101199658B Chinese medicine compound for oral administration for treating vasculitis
07/18/2012CN101108000B Addition-application method of functional properties fat planting food mixture
07/18/2012CN101085019B Traditional Chinese medicinal composition containing red sage root, notoginseng, safflower and musk or muscone and its preparation
07/18/2012CN101085016B Traditional Chinese medicinal composition containing red sage root, notoginseng and ginseng or codonopsis pilosula and its preparation
07/18/2012CN101085004B Traditional Chinese medicinal composition containing red sage root, ligusticum wallichii and borneol or storax and its preparation
07/17/2012US8222405 Phenylalanine derivatives
07/17/2012US8222238 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
07/17/2012US8222231 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
07/17/2012US8221794 Anti-angiogenic nanoparticle compositions
07/17/2012US8221786 Pharmaceutical formulations containing an SGLT2 inhibitor
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012CA2718348C Orally administered peptides to ameliorate atherosclerosis
07/17/2012CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
07/17/2012CA2518676C Use of diazoxide in the treatment of ischemia retinae
07/17/2012CA2492659C 6-(3-pyridyl-methylamino)purine derivatives and their use as antiproliferative agents
07/17/2012CA2488373C N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
07/17/2012CA2476538C Use of erythropoietin for the preventive or curative treatment of cardiac failure
07/17/2012CA2465805C Beneficial effect of distiller's grain in cardiovascular disease
07/17/2012CA2451704C Fortified rice bran food product and method for promoting cardiovascular health
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/17/2012CA2418984C Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
07/17/2012CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof
07/17/2012CA2322559C Compositions and methods for modulating vascularization
07/12/2012WO2012094512A2 Myocardial tissue targeting peptides
07/12/2012WO2012094437A2 Nicotinic receptor non-competitive antagonists
07/12/2012WO2012094033A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
07/12/2012WO2012058585A3 Treatment of heart failure with natriuretic peptides
07/12/2012WO2012057492A9 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
07/12/2012WO2011116245A3 Methods of treating inflammation
07/12/2012US20120180147 Microrna-24
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178813 Lipid-lowering antidiabetic agent
07/12/2012US20120178809 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
07/12/2012US20120178792 Drg11-responsive (dragon) gene family
07/12/2012US20120178789 Novel pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
07/12/2012US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System
07/12/2012US20120178783 Hdac inhibitors
07/12/2012US20120178781 Kappa opioid receptor ligands
07/12/2012US20120178777 Medicaments for Inhibiting Thrombus Formation
07/12/2012US20120178774 Toll-like receptor modulators and uses thereof
07/12/2012US20120178770 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178758 Styryl-triazine derivatives and their therapeutical applications
07/12/2012US20120178752 Rho kinase inhibitors
07/12/2012US20120178750 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178733 Factor xa inhibitors
07/12/2012US20120178729 Crystalline form i rosuvastatin zinc salt
07/12/2012US20120178723 Heteroaryls and uses thereof
07/12/2012US20120178720 Bisphosphonates as Inhibitors of Acid Sphingomyelinase
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178708 Phenethylsulfone isoindoline derivatives and their use
07/12/2012US20120178689 Methods of treatment with natriuretic peptides
07/12/2012US20120178685 Fgf21 mutants and uses thereof
07/12/2012US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178676 Pegylated c-peptide
07/12/2012US20120178670 Acylated glucagon analogues
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178666 Prodrugs of guanfacine
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177738 Green tea extracts of improved bioavailability
07/12/2012US20120177733 Solid dosage forms of valsartan and amlodipine and method of making the same
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177706 Stable combinations of amlodipine besylate and benazepril hydrochloride
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom
07/12/2012US20120177693 Deep lung pulmonary delivery of treprostinil
07/12/2012US20120177690 Use of rapamycin derivatives in vasculopathies and xenotransplantation
07/12/2012US20120177646 Fgf21 mutants and uses thereof
07/12/2012US20120177631 Composition for Health Promoting Compounds
07/12/2012US20120177627 Upregulation of integrin linked kinase (ilk) to provide cardioprotective effects
07/12/2012US20120177626 Hdl comprising a therapeutic agent and use in therapy
07/12/2012US20120177623 Compositions for Boosting Metabolism, Assisting Weight Loss, and Promoting Cardiovascular Health
07/12/2012US20120177616 Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
07/12/2012US20120177613 Use of gingival fibroblasts for vascular cell therapy
07/12/2012US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177594 Polyion complex comprising phd2 expression inhibiting substance
07/12/2012DE102011008070A1 Use of tocotrienol for prevention, aftercare, treatment or auxiliary treatment of proliferative diseases, inflammatory diseases, heart disease, diseases of nervous system, and aftercare of surgical interventions or mitigation of swelling
07/12/2012CA2834968A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
07/12/2012CA2823848A1 Nicotinic receptor non-competitive antagonists
07/11/2012EP2474549A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type I inhibitors
07/11/2012EP2474325A1 Drug composition for angiogenesis therapy
07/11/2012EP2474239A1 Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development
07/11/2012EP2473518A2 Stabilized melanocortin ligands
07/11/2012EP2473199A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders
07/11/2012EP2473196A2 Sdf-1 delivery for treating ischemic tissue
07/11/2012EP2473178A2 Composition for the treatment of hemorrhoids and related diseases
07/11/2012EP2473172A2 Bisphosphonate compositions and methods for treating heart failure
07/11/2012EP2473167A1 Use of irbesartan for the preparation of a medicament for the prevention of hospitalization for heart failure.
07/11/2012EP2138489B1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
07/11/2012EP2010535B1 Thioxanthine derivatives and their use as inhibitors of mpo
1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 1595